Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008 From http://news./s/nm/20080117/hl_nm/drugs_studies_dc_2 posted today, the story is that drug companies sort of neglect in many instances to report on unfavorable outcomes of their clinical trials. This particular story concerns antidepressants, but do we think they behave any differently when it comes to reporting on their biggest money-makers? And haven't we all heard that Lipitor is the biggest of the big? No doubt some of its competitors aren't far behind. Here's a little snippet from the story, "For example, of the seven negative studies done on GlaxoKline's Paxil, five were never published. The researchers found three studies for GSK's Wellbutrin SR, but the two negative ones never reached print. "There were five studies for Pfizer's Zoloft, but the three showing the drug to be ineffective were not published. A fourth study, ruled questionable by the FDA, was written and published to make it appear that the drug worked." Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.